Tag: Spineart
Spineart secures CHF20 million funding following completed enrolment in IDE trials
Spineart has announced that it has successfully raised CHF20 million in convertible financing—an announcement that follows the completion of enrolment in the company’s two BAGUERA C...
US FDA clears Spineart Juliet Ti lumbar interbody devices
Spineart has received 510(k) clearances from the US Food and Drug Administration to market its new Juliet Ti lumbar interbody systems in the USA....